Drug interactions
Omega + Reteplase
Severity: Minor
Omega and Reteplase: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Reteplase is a thrombolytic with a substantial bleeding risk. Omega-3 fatty acids may slightly impair platelet function, which could marginally add to hemorrhagic risk, though the effect is probably small compared with the thrombolytic itself.
What this interaction means in plain words
Omega and Reteplase have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive pharmacodynamic effect of mild omega-3 antiplatelet activity and plasminogen activator-driven fibrinolysis.
What to do
No routine change is needed because reteplase is given acutely; monitor for bleeding according to standard thrombolysis protocols. Hold omega-3 supplements during the acute episode.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Omega and Reteplase, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Frequently asked questions
Can I take Omega with Reteplase?
MediHelp rates the interaction as minor. Omega and Reteplase have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Reteplase is a thrombolytic with a substantial bleeding risk. Omega-3 fatty acids may slightly impair platelet function, which could marginally add to hemorrhagic risk, though the effect is probably small compared with the thrombolytic itself.
How serious is the interaction between Omega and Reteplase?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed because reteplase is given acutely; monitor for bleeding according to standard thrombolysis protocols. Hold omega-3 supplements during the acute episode.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
